ADPTAdaptive Biotechnologies Corp
ADPT
Adaptive Biotechnologies Corp4,300
Mkt Cap
$1.91BVolume
55,776.0052W High
$20.7652W Low
$6.68PE Ratio
-31.13ADPT Fundamentals
Price
$12.63Prev Close
$12.41Open
$12.2350D MA
$15.88Beta
1.70Avg. Volume
1.86MEPS (Annual)
-$0.3922P/B
8.72Rev/Employee
$443,871.79$2,453.55
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 6.7% - Here's What Happened
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 6.7% - Here's What Happened...
MarketBeat·3d ago
Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year
Key PointsAn executive at Adaptive Biotechnologies reported the sale of 179,703 shares for about $2.37 million, based on a weighted average price of around $13.21 per share during March 11-13, 2026...
Nasdaq News: Markets·4d ago
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommen...
MarketBeat·4d ago
Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction that occurred on Friday, March 20th. The shares...
MarketBeat·6d ago
Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares of Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the business's stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $13.37, for a total value of $254,832.20. Following the transaction...
MarketBeat·7d ago
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $263,599.80 in Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $13.83, for a total value of $263,599.80. Following the completion of...
MarketBeat·7d ago
Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $13.18, for a total value of $251,210.80. Following the completion of the...
MarketBeat·12d ago
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $255,594.60 in Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of Adaptive Biotechnologies stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $13.41, for a total value of $255,594.60. Following the sale, the chief...
MarketBeat·12d ago
Adaptive Biotechnologies Corporation $ADPT Shares Bought by Algert Global LLC
Algert Global LLC raised its holdings in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 215.7% in the third quarter, according to the company in its most recent disclosure with...
MarketBeat·13d ago
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading Volume - Here's Why
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading Volume - Still a Buy...
MarketBeat·14d ago
<
1
2
...
>